Global Implantable Infusion Port Market Growth 2026-2032

July 2026 | 134 pages | ID: G9E5D76D03E5EN
LP Information

US$ 3,660.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
The global Implantable Infusion Port market size is predicted to grow from US$ 577 million in 2025 to US$ 897 million in 2032; it is expected to grow at a CAGR of 6.5% from 2026 to 2032.

Implantable infusion port is a closed vein infusion device that is completely implanted subcutaneously and can be left in the body for a long time. It consists of two parts: an injection base (infusion port base) that can be punctured and a venous catheter connected to it. Through a small surgery, the tip of the catheter is placed in the central vein (such as the superior vena cava), and the injection base is completely buried in subcutaneous tissue in areas such as the clavicle or chest wall. When in use, medical staff need to use specialized non-invasive needles to puncture the injection site through the skin for drug infusion, intravenous chemotherapy, parenteral nutrition support, or blood collection. Its core advantage lies in effectively avoiding the pain of repeated peripheral venipuncture, reducing the risk of drug extravasation and the incidence of central venous catheter-related infections. At the same time, due to the device being completely buried subcutaneously, patients can shower normally and engage in mild activities during treatment intervals, significantly improving the quality of life and treatment comfort of long-term treatment patients (such as tumor chemotherapy).

The midstream of the implantable infusion port industry chain is mainly composed of manufacturers of infusion ports and supporting specialized needles. With high technological barriers and strong pricing power, this link generally maintains a lucrative profit margin. Although the public information does not directly disclose the gross profit margin of the infusion port itself, as a high-value consumable of the same type, the specialized needle for implantable drug delivery devices has been included in the scope of centralized procurement, with a gross profit margin of about 58%.

The average price of implantable infusion ports in 2025 is 280 US dollars per piece, with a sales volume of 2.1071 million pieces and a total production capacity of 2.96 million pieces.

The implantable infusion port has evolved from a simple ?chemotherapy venous access? to a landmark solution that balances treatment benefits and quality of life in the era of chronic disease management for tumors. With targeted and immunotherapy significantly extending the survival of cancer patients, the shortcomings of traditional repeated peripheral puncture and peripheral central venous catheter (PICC) in terms of long-term catheterization comfort, infection risk, and daily life restrictions have become increasingly prominent. The infusion port completely eliminates the ?tail? exposed outside the body by completely concealing the catheter opening under the skin, fundamentally reducing the risk of catheter-related bloodstream infections and thrombosis. Although its initial implantation cost is high, for patients who require long-term chemotherapy or parenteral nutrition, its extremely low long-term maintenance cost, lower incidence of complications, and ability to allow patients to bathe normally and engage in high-intensity activities form significant health economic advantages. Therefore, from a global perspective, the infusion port is an important technical support for upgrading the modern tumor treatment concept of ?high-quality survival with cancer?.

The future trend of implantable infusion ports will evolve around four directions: intelligent monitoring, minimally invasive implantation, material innovation, and industrial upgrading. At the level of technological innovation, devices are developing towards ?smart ports? that integrate biosensors and IoT technology, such as real-time warning of infection risks through built-in pH and lactate sensors, or wireless monitoring on mobile phones through NFC near-field communication; Domestic enterprises are also integrating technologies such as optical cell detection into port systems, exploring new paths for real-time dynamic monitoring. At the clinical operational level, implantation technology is upgrading from the traditional ?blind puncture? to the dual guidance and precision mode of ?ultrasound guidance+electrocardiogram positioning?. This not only achieves visualization and synchronization of intraoperative ?puncture positioning?, greatly reducing the risk of radiation exposure and vascular damage, but also promotes new approaches such as hand arm ports due to their aesthetic appeal and convenience. In addition, with the continuous breakthroughs of domestic brands in 3D printing, anti infective coatings, and biocompatible materials, as well as the reshaping of the market pattern by centralized procurement policies, product accessibility will be greatly improved, and the industry is transforming from relying on imported ?high-value consumables? to independently controllable ?universal intelligent terminals?.

LP Information, Inc. (LPI) ' newest research report, the ?Implantable Infusion Port Industry Forecast? looks at past sales and reviews total world Implantable Infusion Port sales in 2025, providing a comprehensive analysis by region and market sector of projected Implantable Infusion Port sales for 2026 through 2032. With Implantable Infusion Port sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Implantable Infusion Port industry.

This Insight Report provides a comprehensive analysis of the global Implantable Infusion Port landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Implantable Infusion Port portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Implantable Infusion Port market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Implantable Infusion Port and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Implantable Infusion Port.

This report presents a comprehensive overview, market shares, and growth opportunities of Implantable Infusion Port market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:
  • Single Chamber Infusion Port
  • Double Chamber Infusion Port
Segmentation by Port Location:
  • Chest Wall Port
  • Upper Arm Port
  • Other Ports
Segmentation by Material Classification:
  • Titanium Alloy Material
  • Polymer Material
Segmentation by Application:
  • Aldult
  • Child
This report also splits the market by region:
  • Americas
    • United States
    • Canada
    • Mexico
    • Brazil
  • APAC
    • China
    • Japan
    • Korea
    • Southeast Asia
    • India
    • Australia
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Russia
  • Middle East & Africa
    • Egypt
    • South Africa
    • Israel
    • Turkey
    • GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
  • BD
  • B. Braun Medical
  • AngioDynamics
  • ICU Medical
  • Teleflex
  • Cook Medical
  • Smiths Medical
  • Fresenius Medical Care
  • Vygon
  • PFM Medical
  • Districlass
  • PakuMed
  • Sophysa
  • Baxter
  • Nipro Corporation
  • Terumo Corporation
  • Edwards Lifesciences
  • Suzhou Linhua Medical Equipment
  • Weican (Nanjing) Medical Technology Development Co., Ltd.
  • Jingmeide (Shenzhen) Medical Technology Co., Ltd.
Key Questions Addressed in this Report
  • What is the 10-year outlook for the global Implantable Infusion Port market?
  • What factors are driving Implantable Infusion Port market growth, globally and by region?
  • Which technologies are poised for the fastest growth by market and region?
  • How doImplantable Infusion Port market opportunities vary by end market size?
  • How does Implantable Infusion Port break out by Type, by Application?
1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Implantable Infusion Port Annual Sales 2021-2032
  2.1.2 World Current & Future Analysis for Implantable Infusion Port by Geographic Region, 2021, 2025 & 2032
  2.1.3 World Current & Future Analysis for Implantable Infusion Port by Country/Region, 2021, 2025 & 2032
2.2 Implantable Infusion Port Segment by Type
  2.2.1 Single Chamber Infusion Port
  2.2.2 Double Chamber Infusion Port
  2.2.3 Implantable Infusion Port Sales by Type
    2.2.3.1 Global Implantable Infusion Port Sales Market Share by Type (2021-2026)
    2.2.3.2 Global Implantable Infusion Port Revenue and Market Share by Type (2021-2026)
    2.2.3.3 Global Implantable Infusion Port Sale Price by Type (2021-2026)
2.3 Implantable Infusion Port Segment by Port Location
  2.3.1 Chest Wall Port
  2.3.2 Upper Arm Port
  2.3.3 Other Ports
  2.3.4 Implantable Infusion Port Sales by Port Location
    2.3.4.1 Global Implantable Infusion Port Sales Market Share by Port Location (2021-2026)
    2.3.4.2 Global Implantable Infusion Port Revenue and Market Share by Port Location (2021-2026)
    2.3.4.3 Global Implantable Infusion Port Sale Price by Port Location (2021-2026)
2.4 Implantable Infusion Port Segment by Material Classification
  2.4.1 Titanium Alloy Material
  2.4.2 Polymer Material
  2.4.3 Implantable Infusion Port Sales by Material Classification
    2.4.3.1 Global Implantable Infusion Port Sales Market Share by Material Classification (2021-2026)
    2.4.3.2 Global Implantable Infusion Port Revenue and Market Share by Material Classification (2021-2026)
    2.4.3.3 Global Implantable Infusion Port Sale Price by Material Classification (2021-2026)
2.5 Implantable Infusion Port Segment by Application
  2.5.1 Aldult
  2.5.2 Child
  2.5.3 Implantable Infusion Port Sales by Application
    2.5.3.1 Global Implantable Infusion Port Sale Market Share by Application (2021-2026)
    2.5.3.2 Global Implantable Infusion Port Revenue and Market Share by Application (2021-2026)
    2.5.3.3 Global Implantable Infusion Port Sale Price by Application (2021-2026)

3 GLOBAL BY COMPANY

3.1 Global Implantable Infusion Port Breakdown Data by Company
  3.1.1 Global Implantable Infusion Port Annual Sales by Company (2021-2026)
  3.1.2 Global Implantable Infusion Port Sales Market Share by Company (2021-2026)
3.2 Global Implantable Infusion Port Annual Revenue by Company (2021-2026)
  3.2.1 Global Implantable Infusion Port Revenue by Company (2021-2026)
  3.2.2 Global Implantable Infusion Port Revenue Market Share by Company (2021-2026)
3.3 Global Implantable Infusion Port Sale Price by Company
3.4 Key Manufacturers Implantable Infusion Port Producing Area Distribution, Sales Area, Product Type
  3.4.1 Key Manufacturers Implantable Infusion Port Product Location Distribution
  3.4.2 Players Implantable Infusion Port Products Offered
3.5 Market Concentration Rate Analysis
  3.5.1 Competition Landscape Analysis
  3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy

4 WORLD HISTORIC REVIEW FOR IMPLANTABLE INFUSION PORT BY GEOGRAPHIC REGION

4.1 World Historic Implantable Infusion Port Market Size by Geographic Region (2021-2026)
  4.1.1 Global Implantable Infusion Port Annual Sales by Geographic Region (2021-2026)
  4.1.2 Global Implantable Infusion Port Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Implantable Infusion Port Market Size by Country/Region (2021-2026)
  4.2.1 Global Implantable Infusion Port Annual Sales by Country/Region (2021-2026)
  4.2.2 Global Implantable Infusion Port Annual Revenue by Country/Region (2021-2026)
4.3 Americas Implantable Infusion Port Sales Growth
4.4 APAC Implantable Infusion Port Sales Growth
4.5 Europe Implantable Infusion Port Sales Growth
4.6 Middle East & Africa Implantable Infusion Port Sales Growth

5 AMERICAS

5.1 Americas Implantable Infusion Port Sales by Country
  5.1.1 Americas Implantable Infusion Port Sales by Country (2021-2026)
  5.1.2 Americas Implantable Infusion Port Revenue by Country (2021-2026)
5.2 Americas Implantable Infusion Port Sales by Type (2021-2026)
5.3 Americas Implantable Infusion Port Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Implantable Infusion Port Sales by Region
  6.1.1 APAC Implantable Infusion Port Sales by Region (2021-2026)
  6.1.2 APAC Implantable Infusion Port Revenue by Region (2021-2026)
6.2 APAC Implantable Infusion Port Sales by Type (2021-2026)
6.3 APAC Implantable Infusion Port Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan

7 EUROPE

7.1 Europe Implantable Infusion Port by Country
  7.1.1 Europe Implantable Infusion Port Sales by Country (2021-2026)
  7.1.2 Europe Implantable Infusion Port Revenue by Country (2021-2026)
7.2 Europe Implantable Infusion Port Sales by Type (2021-2026)
7.3 Europe Implantable Infusion Port Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Implantable Infusion Port by Country
  8.1.1 Middle East & Africa Implantable Infusion Port Sales by Country (2021-2026)
  8.1.2 Middle East & Africa Implantable Infusion Port Revenue by Country (2021-2026)
8.2 Middle East & Africa Implantable Infusion Port Sales by Type (2021-2026)
8.3 Middle East & Africa Implantable Infusion Port Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 MANUFACTURING COST STRUCTURE ANALYSIS

10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Implantable Infusion Port
10.3 Manufacturing Process Analysis of Implantable Infusion Port
10.4 Industry Chain Structure of Implantable Infusion Port

11 MARKETING, DISTRIBUTORS AND CUSTOMER

11.1 Sales Channel
  11.1.1 Direct Channels
  11.1.2 Indirect Channels
11.2 Implantable Infusion Port Distributors
11.3 Implantable Infusion Port Customer

12 WORLD FORECAST REVIEW FOR IMPLANTABLE INFUSION PORT BY GEOGRAPHIC REGION

12.1 Global Implantable Infusion Port Market Size Forecast by Region
  12.1.1 Global Implantable Infusion Port Forecast by Region (2027-2032)
  12.1.2 Global Implantable Infusion Port Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Implantable Infusion Port Forecast by Type (2027-2032)
12.7 Global Implantable Infusion Port Forecast by Application (2027-2032)

13 KEY PLAYERS ANALYSIS

13.1 BD
  13.1.1 BD Company Information
  13.1.2 BD Implantable Infusion Port Product Portfolios and Specifications
  13.1.3 BD Implantable Infusion Port Sales, Revenue, Price and Gross Margin (2021-2026)
  13.1.4 BD Main Business Overview
  13.1.5 BD Latest Developments
13.2 B. Braun Medical
  13.2.1 B. Braun Medical Company Information
  13.2.2 B. Braun Medical Implantable Infusion Port Product Portfolios and Specifications
  13.2.3 B. Braun Medical Implantable Infusion Port Sales, Revenue, Price and Gross Margin (2021-2026)
  13.2.4 B. Braun Medical Main Business Overview
  13.2.5 B. Braun Medical Latest Developments
13.3 AngioDynamics
  13.3.1 AngioDynamics Company Information
  13.3.2 AngioDynamics Implantable Infusion Port Product Portfolios and Specifications
  13.3.3 AngioDynamics Implantable Infusion Port Sales, Revenue, Price and Gross Margin (2021-2026)
  13.3.4 AngioDynamics Main Business Overview
  13.3.5 AngioDynamics Latest Developments
13.4 ICU Medical
  13.4.1 ICU Medical Company Information
  13.4.2 ICU Medical Implantable Infusion Port Product Portfolios and Specifications
  13.4.3 ICU Medical Implantable Infusion Port Sales, Revenue, Price and Gross Margin (2021-2026)
  13.4.4 ICU Medical Main Business Overview
  13.4.5 ICU Medical Latest Developments
13.5 Teleflex
  13.5.1 Teleflex Company Information
  13.5.2 Teleflex Implantable Infusion Port Product Portfolios and Specifications
  13.5.3 Teleflex Implantable Infusion Port Sales, Revenue, Price and Gross Margin (2021-2026)
  13.5.4 Teleflex Main Business Overview
  13.5.5 Teleflex Latest Developments
13.6 Cook Medical
  13.6.1 Cook Medical Company Information
  13.6.2 Cook Medical Implantable Infusion Port Product Portfolios and Specifications
  13.6.3 Cook Medical Implantable Infusion Port Sales, Revenue, Price and Gross Margin (2021-2026)
  13.6.4 Cook Medical Main Business Overview
  13.6.5 Cook Medical Latest Developments
13.7 Smiths Medical
  13.7.1 Smiths Medical Company Information
  13.7.2 Smiths Medical Implantable Infusion Port Product Portfolios and Specifications
  13.7.3 Smiths Medical Implantable Infusion Port Sales, Revenue, Price and Gross Margin (2021-2026)
  13.7.4 Smiths Medical Main Business Overview
  13.7.5 Smiths Medical Latest Developments
13.8 Fresenius Medical Care
  13.8.1 Fresenius Medical Care Company Information
  13.8.2 Fresenius Medical Care Implantable Infusion Port Product Portfolios and Specifications
  13.8.3 Fresenius Medical Care Implantable Infusion Port Sales, Revenue, Price and Gross Margin (2021-2026)
  13.8.4 Fresenius Medical Care Main Business Overview
  13.8.5 Fresenius Medical Care Latest Developments
13.9 Vygon
  13.9.1 Vygon Company Information
  13.9.2 Vygon Implantable Infusion Port Product Portfolios and Specifications
  13.9.3 Vygon Implantable Infusion Port Sales, Revenue, Price and Gross Margin (2021-2026)
  13.9.4 Vygon Main Business Overview
  13.9.5 Vygon Latest Developments
13.10 PFM Medical
  13.10.1 PFM Medical Company Information
  13.10.2 PFM Medical Implantable Infusion Port Product Portfolios and Specifications
  13.10.3 PFM Medical Implantable Infusion Port Sales, Revenue, Price and Gross Margin (2021-2026)
  13.10.4 PFM Medical Main Business Overview
  13.10.5 PFM Medical Latest Developments
13.11 Districlass
  13.11.1 Districlass Company Information
  13.11.2 Districlass Implantable Infusion Port Product Portfolios and Specifications
  13.11.3 Districlass Implantable Infusion Port Sales, Revenue, Price and Gross Margin (2021-2026)
  13.11.4 Districlass Main Business Overview
  13.11.5 Districlass Latest Developments
13.12 PakuMed
  13.12.1 PakuMed Company Information
  13.12.2 PakuMed Implantable Infusion Port Product Portfolios and Specifications
  13.12.3 PakuMed Implantable Infusion Port Sales, Revenue, Price and Gross Margin (2021-2026)
  13.12.4 PakuMed Main Business Overview
  13.12.5 PakuMed Latest Developments
13.13 Sophysa
  13.13.1 Sophysa Company Information
  13.13.2 Sophysa Implantable Infusion Port Product Portfolios and Specifications
  13.13.3 Sophysa Implantable Infusion Port Sales, Revenue, Price and Gross Margin (2021-2026)
  13.13.4 Sophysa Main Business Overview
  13.13.5 Sophysa Latest Developments
13.14 Baxter
  13.14.1 Baxter Company Information
  13.14.2 Baxter Implantable Infusion Port Product Portfolios and Specifications
  13.14.3 Baxter Implantable Infusion Port Sales, Revenue, Price and Gross Margin (2021-2026)
  13.14.4 Baxter Main Business Overview
  13.14.5 Baxter Latest Developments
13.15 Nipro Corporation
  13.15.1 Nipro Corporation Company Information
  13.15.2 Nipro Corporation Implantable Infusion Port Product Portfolios and Specifications
  13.15.3 Nipro Corporation Implantable Infusion Port Sales, Revenue, Price and Gross Margin (2021-2026)
  13.15.4 Nipro Corporation Main Business Overview
  13.15.5 Nipro Corporation Latest Developments
13.16 Terumo Corporation
  13.16.1 Terumo Corporation Company Information
  13.16.2 Terumo Corporation Implantable Infusion Port Product Portfolios and Specifications
  13.16.3 Terumo Corporation Implantable Infusion Port Sales, Revenue, Price and Gross Margin (2021-2026)
  13.16.4 Terumo Corporation Main Business Overview
  13.16.5 Terumo Corporation Latest Developments
13.17 Edwards Lifesciences
  13.17.1 Edwards Lifesciences Company Information
  13.17.2 Edwards Lifesciences Implantable Infusion Port Product Portfolios and Specifications
  13.17.3 Edwards Lifesciences Implantable Infusion Port Sales, Revenue, Price and Gross Margin (2021-2026)
  13.17.4 Edwards Lifesciences Main Business Overview
  13.17.5 Edwards Lifesciences Latest Developments
13.18 Suzhou Linhua Medical Equipment
  13.18.1 Suzhou Linhua Medical Equipment Company Information
  13.18.2 Suzhou Linhua Medical Equipment Implantable Infusion Port Product Portfolios and Specifications
  13.18.3 Suzhou Linhua Medical Equipment Implantable Infusion Port Sales, Revenue, Price and Gross Margin (2021-2026)
  13.18.4 Suzhou Linhua Medical Equipment Main Business Overview
  13.18.5 Suzhou Linhua Medical Equipment Latest Developments
13.19 Weican (Nanjing) Medical Technology Development Co., Ltd.
  13.19.1 Weican (Nanjing) Medical Technology Development Co., Ltd. Company Information
  13.19.2 Weican (Nanjing) Medical Technology Development Co., Ltd. Implantable Infusion Port Product Portfolios and Specifications
  13.19.3 Weican (Nanjing) Medical Technology Development Co., Ltd. Implantable Infusion Port Sales, Revenue, Price and Gross Margin (2021-2026)
  13.19.4 Weican (Nanjing) Medical Technology Development Co., Ltd. Main Business Overview
  13.19.5 Weican (Nanjing) Medical Technology Development Co., Ltd. Latest Developments
13.20 Jingmeide (Shenzhen) Medical Technology Co., Ltd.
  13.20.1 Jingmeide (Shenzhen) Medical Technology Co., Ltd. Company Information
  13.20.2 Jingmeide (Shenzhen) Medical Technology Co., Ltd. Implantable Infusion Port Product Portfolios and Specifications
  13.20.3 Jingmeide (Shenzhen) Medical Technology Co., Ltd. Implantable Infusion Port Sales, Revenue, Price and Gross Margin (2021-2026)
  13.20.4 Jingmeide (Shenzhen) Medical Technology Co., Ltd. Main Business Overview
  13.20.5 Jingmeide (Shenzhen) Medical Technology Co., Ltd. Latest Developments

14 RESEARCH FINDINGS AND CONCLUSION



LIST OF TABLES

Table 1. Implantable Infusion Port Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Implantable Infusion Port Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Single Chamber Infusion Port
Table 4. Major Players of Double Chamber Infusion Port
Table 5. Global Implantable Infusion Port Sales by Type (2021-2026) & (K Units)
Table 6. Global Implantable Infusion Port Sales Market Share by Type (2021-2026)
Table 7. Global Implantable Infusion Port Revenue by Type (2021-2026) & ($ million)
Table 8. Global Implantable Infusion Port Revenue Market Share by Type (2021-2026)
Table 9. Global Implantable Infusion Port Sale Price by Type (2021-2026) & (US$/Unit)
Table 10. Major Players of Chest Wall Port
Table 11. Major Players of Upper Arm Port
Table 12. Major Players of Other Ports
Table 13. Global Implantable Infusion Port Sales by Port Location (2021-2026) & (K Units)
Table 14. Global Implantable Infusion Port Sales Market Share by Port Location (2021-2026)
Table 15. Global Implantable Infusion Port Revenue by Port Location (2021-2026) & ($ million)
Table 16. Global Implantable Infusion Port Revenue Market Share by Port Location (2021-2026)
Table 17. Global Implantable Infusion Port Sale Price by Port Location (2021-2026) & (US$/Unit)
Table 18. Major Players of Titanium Alloy Material
Table 19. Major Players of Polymer Material
Table 20. Global Implantable Infusion Port Sales by Material Classification (2021-2026) & (K Units)
Table 21. Global Implantable Infusion Port Sales Market Share by Material Classification (2021-2026)
Table 22. Global Implantable Infusion Port Revenue by Material Classification (2021-2026) & ($ million)
Table 23. Global Implantable Infusion Port Revenue Market Share by Material Classification (2021-2026)
Table 24. Global Implantable Infusion Port Sale Price by Material Classification (2021-2026) & (US$/Unit)
Table 25. Global Implantable Infusion Port Sale by Application (2021-2026) & (K Units)
Table 26. Global Implantable Infusion Port Sale Market Share by Application (2021-2026)
Table 27. Global Implantable Infusion Port Revenue by Application (2021-2026) & ($ million)
Table 28. Global Implantable Infusion Port Revenue Market Share by Application (2021-2026)
Table 29. Global Implantable Infusion Port Sale Price by Application (2021-2026) & (US$/Unit)
Table 30. Global Implantable Infusion Port Sales by Company (2021-2026) & (K Units)
Table 31. Global Implantable Infusion Port Sales Market Share by Company (2021-2026)
Table 32. Global Implantable Infusion Port Revenue by Company (2021-2026) & ($ millions)
Table 33. Global Implantable Infusion Port Revenue Market Share by Company (2021-2026)
Table 34. Global Implantable Infusion Port Sale Price by Company (2021-2026) & (US$/Unit)
Table 35. Key Manufacturers Implantable Infusion Port Producing Area Distribution and Sales Area
Table 36. Players Implantable Infusion Port Products Offered
Table 37. Implantable Infusion Port Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 38. New Products and Potential Entrants
Table 39. Market M&A Activity & Strategy
Table 40. Global Implantable Infusion Port Sales by Geographic Region (2021-2026) & (K Units)
Table 41. Global Implantable Infusion Port Sales Market Share Geographic Region (2021-2026)
Table 42. Global Implantable Infusion Port Revenue by Geographic Region (2021-2026) & ($ millions)
Table 43. Global Implantable Infusion Port Revenue Market Share by Geographic Region (2021-2026)
Table 44. Global Implantable Infusion Port Sales by Country/Region (2021-2026) & (K Units)
Table 45. Global Implantable Infusion Port Sales Market Share by Country/Region (2021-2026)
Table 46. Global Implantable Infusion Port Revenue by Country/Region (2021-2026) & ($ millions)
Table 47. Global Implantable Infusion Port Revenue Market Share by Country/Region (2021-2026)
Table 48. Americas Implantable Infusion Port Sales by Country (2021-2026) & (K Units)
Table 49. Americas Implantable Infusion Port Sales Market Share by Country (2021-2026)
Table 50. Americas Implantable Infusion Port Revenue by Country (2021-2026) & ($ millions)
Table 51. Americas Implantable Infusion Port Sales by Type (2021-2026) & (K Units)
Table 52. Americas Implantable Infusion Port Sales by Application (2021-2026) & (K Units)
Table 53. APAC Implantable Infusion Port Sales by Region (2021-2026) & (K Units)
Table 54. APAC Implantable Infusion Port Sales Market Share by Region (2021-2026)
Table 55. APAC Implantable Infusion Port Revenue by Region (2021-2026) & ($ millions)
Table 56. APAC Implantable Infusion Port Sales by Type (2021-2026) & (K Units)
Table 57. APAC Implantable Infusion Port Sales by Application (2021-2026) & (K Units)
Table 58. Europe Implantable Infusion Port Sales by Country (2021-2026) & (K Units)
Table 59. Europe Implantable Infusion Port Revenue by Country (2021-2026) & ($ millions)
Table 60. Europe Implantable Infusion Port Sales by Type (2021-2026) & (K Units)
Table 61. Europe Implantable Infusion Port Sales by Application (2021-2026) & (K Units)
Table 62. Middle East & Africa Implantable Infusion Port Sales by Country (2021-2026) & (K Units)
Table 63. Middle East & Africa Implantable Infusion Port Revenue Market Share by Country (2021-2026)
Table 64. Middle East & Africa Implantable Infusion Port Sales by Type (2021-2026) & (K Units)
Table 65. Middle East & Africa Implantable Infusion Port Sales by Application (2021-2026) & (K Units)
Table 66. Key Market Drivers & Growth Opportunities of Implantable Infusion Port
Table 67. Key Market Challenges & Risks of Implantable Infusion Port
Table 68. Key Industry Trends of Implantable Infusion Port
Table 69. Implantable Infusion Port Raw Material
Table 70. Key Suppliers of Raw Materials
Table 71. Implantable Infusion Port Distributors List
Table 72. Implantable Infusion Port Customer List
Table 73. Global Implantable Infusion Port Sales Forecast by Region (2027-2032) & (K Units)
Table 74. Global Implantable Infusion Port Revenue Forecast by Region (2027-2032) & ($ millions)
Table 75. Americas Implantable Infusion Port Sales Forecast by Country (2027-2032) & (K Units)
Table 76. Americas Implantable Infusion Port Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 77. APAC Implantable Infusion Port Sales Forecast by Region (2027-2032) & (K Units)
Table 78. APAC Implantable Infusion Port Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 79. Europe Implantable Infusion Port Sales Forecast by Country (2027-2032) & (K Units)
Table 80. Europe Implantable Infusion Port Revenue Forecast by Country (2027-2032) & ($ millions)
Table 81. Middle East & Africa Implantable Infusion Port Sales Forecast by Country (2027-2032) & (K Units)
Table 82. Middle East & Africa Implantable Infusion Port Revenue Forecast by Country (2027-2032) & ($ millions)
Table 83. Global Implantable Infusion Port Sales Forecast by Type (2027-2032) & (K Units)
Table 84. Global Implantable Infusion Port Revenue Forecast by Type (2027-2032) & ($ millions)
Table 85. Global Implantable Infusion Port Sales Forecast by Application (2027-2032) & (K Units)
Table 86. Global Implantable Infusion Port Revenue Forecast by Application (2027-2032) & ($ millions)
Table 87. BD Basic Information, Implantable Infusion Port Manufacturing Base, Sales Area and Its Competitors
Table 88. BD Implantable Infusion Port Product Portfolios and Specifications
Table 89. BD Implantable Infusion Port Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 90. BD Main Business
Table 91. BD Latest Developments
Table 92. B. Braun Medical Basic Information, Implantable Infusion Port Manufacturing Base, Sales Area and Its Competitors
Table 93. B. Braun Medical Implantable Infusion Port Product Portfolios and Specifications
Table 94. B. Braun Medical Implantable Infusion Port Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 95. B. Braun Medical Main Business
Table 96. B. Braun Medical Latest Developments
Table 97. AngioDynamics Basic Information, Implantable Infusion Port Manufacturing Base, Sales Area and Its Competitors
Table 98. AngioDynamics Implantable Infusion Port Product Portfolios and Specifications
Table 99. AngioDynamics Implantable Infusion Port Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 100. AngioDynamics Main Business
Table 101. AngioDynamics Latest Developments
Table 102. ICU Medical Basic Information, Implantable Infusion Port Manufacturing Base, Sales Area and Its Competitors
Table 103. ICU Medical Implantable Infusion Port Product Portfolios and Specifications
Table 104. ICU Medical Implantable Infusion Port Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 105. ICU Medical Main Business
Table 106. ICU Medical Latest Developments
Table 107. Teleflex Basic Information, Implantable Infusion Port Manufacturing Base, Sales Area and Its Competitors
Table 108. Teleflex Implantable Infusion Port Product Portfolios and Specifications
Table 109. Teleflex Implantable Infusion Port Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 110. Teleflex Main Business
Table 111. Teleflex Latest Developments
Table 112. Cook Medical Basic Information, Implantable Infusion Port Manufacturing Base, Sales Area and Its Competitors
Table 113. Cook Medical Implantable Infusion Port Product Portfolios and Specifications
Table 114. Cook Medical Implantable Infusion Port Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 115. Cook Medical Main Business
Table 116. Cook Medical Latest Developments
Table 117. Smiths Medical Basic Information, Implantable Infusion Port Manufacturing Base, Sales Area and Its Competitors
Table 118. Smiths Medical Implantable Infusion Port Product Portfolios and Specifications
Table 119. Smiths Medical Implantable Infusion Port Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 120. Smiths Medical Main Business
Table 121. Smiths Medical Latest Developments
Table 122. Fresenius Medical Care Basic Information, Implantable Infusion Port Manufacturing Base, Sales Area and Its Competitors
Table 123. Fresenius Medical Care Implantable Infusion Port Product Portfolios and Specifications
Table 124. Fresenius Medical Care Implantable Infusion Port Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 125. Fresenius Medical Care Main Business
Table 126. Fresenius Medical Care Latest Developments
Table 127. Vygon Basic Information, Implantable Infusion Port Manufacturing Base, Sales Area and Its Competitors
Table 128. Vygon Implantable Infusion Port Product Portfolios and Specifications
Table 129. Vygon Implantable Infusion Port Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 130. Vygon Main Business
Table 131. Vygon Latest Developments
Table 132. PFM Medical Basic Information, Implantable Infusion Port Manufacturing Base, Sales Area and Its Competitors
Table 133. PFM Medical Implantable Infusion Port Product Portfolios and Specifications
Table 134. PFM Medical Implantable Infusion Port Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 135. PFM Medical Main Business
Table 136. PFM Medical Latest Developments
Table 137. Districlass Basic Information, Implantable Infusion Port Manufacturing Base, Sales Area and Its Competitors
Table 138. Districlass Implantable Infusion Port Product Portfolios and Specifications
Table 139. Districlass Implantable Infusion Port Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 140. Districlass Main Business
Table 141. Districlass Latest Developments
Table 142. PakuMed Basic Information, Implantable Infusion Port Manufacturing Base, Sales Area and Its Competitors
Table 143. PakuMed Implantable Infusion Port Product Portfolios and Specifications
Table 144. PakuMed Implantable Infusion Port Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 145. PakuMed Main Business
Table 146. PakuMed Latest Developments
Table 147. Sophysa Basic Information, Implantable Infusion Port Manufacturing Base, Sales Area and Its Competitors
Table 148. Sophysa Implantable Infusion Port Product Portfolios and Specifications
Table 149. Sophysa Implantable Infusion Port Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 150. Sophysa Main Business
Table 151. Sophysa Latest Developments
Table 152. Baxter Basic Information, Implantable Infusion Port Manufacturing Base, Sales Area and Its Competitors
Table 153. Baxter Implantable Infusion Port Product Portfolios and Specifications
Table 154. Baxter Implantable Infusion Port Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 155. Baxter Main Business
Table 156. Baxter Latest Developments
Table 157. Nipro Corporation Basic Information, Implantable Infusion Port Manufacturing Base, Sales Area and Its Competitors
Table 158. Nipro Corporation Implantable Infusion Port Product Portfolios and Specifications
Table 159. Nipro Corporation Implantable Infusion Port Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 160. Nipro Corporation Main Business
Table 161. Nipro Corporation Latest Developments
Table 162. Terumo Corporation Basic Information, Implantable Infusion Port Manufacturing Base, Sales Area and Its Competitors
Table 163. Terumo Corporation Implantable Infusion Port Product Portfolios and Specifications
Table 164. Terumo Corporation Implantable Infusion Port Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 165. Terumo Corporation Main Business
Table 166. Terumo Corporation Latest Developments
Table 167. Edwards Lifesciences Basic Information, Implantable Infusion Port Manufacturing Base, Sales Area and Its Competitors
Table 168. Edwards Lifesciences Implantable Infusion Port Product Portfolios and Specifications
Table 169. Edwards Lifesciences Implantable Infusion Port Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 170. Edwards Lifesciences Main Business
Table 171. Edwards Lifesciences Latest Developments
Table 172. Suzhou Linhua Medical Equipment Basic Information, Implantable Infusion Port Manufacturing Base, Sales Area and Its Competitors
Table 173. Suzhou Linhua Medical Equipment Implantable Infusion Port Product Portfolios and Specifications
Table 174. Suzhou Linhua Medical Equipment Implantable Infusion Port Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 175. Suzhou Linhua Medical Equipment Main Business
Table 176. Suzhou Linhua Medical Equipment Latest Developments
Table 177. Weican (Nanjing) Medical Technology Development Co., Ltd. Basic Information, Implantable Infusion Port Manufacturing Base, Sales Area and Its Competitors
Table 178. Weican (Nanjing) Medical Technology Development Co., Ltd. Implantable Infusion Port Product Portfolios and Specifications
Table 179. Weican (Nanjing) Medical Technology Development Co., Ltd. Implantable Infusion Port Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 180. Weican (Nanjing) Medical Technology Development Co., Ltd. Main Business
Table 181. Weican (Nanjing) Medical Technology Development Co., Ltd. Latest Developments
Table 182. Jingmeide (Shenzhen) Medical Technology Co., Ltd. Basic Information, Implantable Infusion Port Manufacturing Base, Sales Area and Its Competitors
Table 183. Jingmeide (Shenzhen) Medical Technology Co., Ltd. Implantable Infusion Port Product Portfolios and Specifications
Table 184. Jingmeide (Shenzhen) Medical Technology Co., Ltd. Implantable Infusion Port Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 185. Jingmeide (Shenzhen) Medical Technology Co., Ltd. Main Business
Table 186. Jingmeide (Shenzhen) Medical Technology Co., Ltd. Latest Developments

LIST OF FIGURES

Figure 1. Picture of Implantable Infusion Port
Figure 2. Implantable Infusion Port Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Implantable Infusion Port Sales Growth Rate 2021-2032 (K Units)
Figure 7. Global Implantable Infusion Port Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Implantable Infusion Port Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Implantable Infusion Port Sales Market Share by Country/Region (2025)
Figure 10. Implantable Infusion Port Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of Single Chamber Infusion Port
Figure 12. Product Picture of Double Chamber Infusion Port
Figure 13. Global Implantable Infusion Port Sales Market Share by Type in 2026
Figure 14. Global Implantable Infusion Port Revenue Market Share by Type (2021-2026)
Figure 15. Product Picture of Chest Wall Port
Figure 16. Product Picture of Upper Arm Port
Figure 17. Product Picture of Other Ports
Figure 18. Global Implantable Infusion Port Sales Market Share by Port Location in 2026
Figure 19. Global Implantable Infusion Port Revenue Market Share by Port Location (2021-2026)
Figure 20. Product Picture of Titanium Alloy Material
Figure 21. Product Picture of Polymer Material
Figure 22. Global Implantable Infusion Port Sales Market Share by Material Classification in 2026
Figure 23. Global Implantable Infusion Port Revenue Market Share by Material Classification (2021-2026)
Figure 24. Implantable Infusion Port Consumed in Aldult
Figure 25. Global Implantable Infusion Port Market: Aldult (2021-2026) & (K Units)
Figure 26. Implantable Infusion Port Consumed in Child
Figure 27. Global Implantable Infusion Port Market: Child (2021-2026) & (K Units)
Figure 28. Global Implantable Infusion Port Sale Market Share by Application (2025)
Figure 29. Global Implantable Infusion Port Revenue Market Share by Application in 2025
Figure 30. Implantable Infusion Port Sales by Company in 2025 (K Units)
Figure 31. Global Implantable Infusion Port Sales Market Share by Company in 2025
Figure 32. Implantable Infusion Port Revenue by Company in 2025 ($ millions)
Figure 33. Global Implantable Infusion Port Revenue Market Share by Company in 2025
Figure 34. Global Implantable Infusion Port Sales Market Share by Geographic Region (2021-2026)
Figure 35. Global Implantable Infusion Port Revenue Market Share by Geographic Region in 2025
Figure 36. Americas Implantable Infusion Port Sales 2021-2026 (K Units)
Figure 37. Americas Implantable Infusion Port Revenue 2021-2026 ($ millions)
Figure 38. APAC Implantable Infusion Port Sales 2021-2026 (K Units)
Figure 39. APAC Implantable Infusion Port Revenue 2021-2026 ($ millions)
Figure 40. Europe Implantable Infusion Port Sales 2021-2026 (K Units)
Figure 41. Europe Implantable Infusion Port Revenue 2021-2026 ($ millions)
Figure 42. Middle East & Africa Implantable Infusion Port Sales 2021-2026 (K Units)
Figure 43. Middle East & Africa Implantable Infusion Port Revenue 2021-2026 ($ millions)
Figure 44. Americas Implantable Infusion Port Sales Market Share by Country in 2025
Figure 45. Americas Implantable Infusion Port Revenue Market Share by Country (2021-2026)
Figure 46. Americas Implantable Infusion Port Sales Market Share by Type (2021-2026)
Figure 47. Americas Implantable Infusion Port Sales Market Share by Application (2021-2026)
Figure 48. United States Implantable Infusion Port Revenue Growth 2021-2026 ($ millions)
Figure 49. Canada Implantable Infusion Port Revenue Growth 2021-2026 ($ millions)
Figure 50. Mexico Implantable Infusion Port Revenue Growth 2021-2026 ($ millions)
Figure 51. Brazil Implantable Infusion Port Revenue Growth 2021-2026 ($ millions)
Figure 52. APAC Implantable Infusion Port Sales Market Share by Region in 2025
Figure 53. APAC Implantable Infusion Port Revenue Market Share by Region (2021-2026)
Figure 54. APAC Implantable Infusion Port Sales Market Share by Type (2021-2026)
Figure 55. APAC Implantable Infusion Port Sales Market Share by Application (2021-2026)
Figure 56. China Implantable Infusion Port Revenue Growth 2021-2026 ($ millions)
Figure 57. Japan Implantable Infusion Port Revenue Growth 2021-2026 ($ millions)
Figure 58. South Korea Implantable Infusion Port Revenue Growth 2021-2026 ($ millions)
Figure 59. Southeast Asia Implantable Infusion Port Revenue Growth 2021-2026 ($ millions)
Figure 60. India Implantable Infusion Port Revenue Growth 2021-2026 ($ millions)
Figure 61. Australia Implantable Infusion Port Revenue Growth 2021-2026 ($ millions)
Figure 62. China Taiwan Implantable Infusion Port Revenue Growth 2021-2026 ($ millions)
Figure 63. Europe Implantable Infusion Port Sales Market Share by Country in 2025
Figure 64. Europe Implantable Infusion Port Revenue Market Share by Country (2021-2026)
Figure 65. Europe Implantable Infusion Port Sales Market Share by Type (2021-2026)
Figure 66. Europe Implantable Infusion Port Sales Market Share by Application (2021-2026)
Figure 67. Germany Implantable Infusion Port Revenue Growth 2021-2026 ($ millions)
Figure 68. France Implantable Infusion Port Revenue Growth 2021-2026 ($ millions)
Figure 69. UK Implantable Infusion Port Revenue Growth 2021-2026 ($ millions)
Figure 70. Italy Implantable Infusion Port Revenue Growth 2021-2026 ($ millions)
Figure 71. Russia Implantable Infusion Port Revenue Growth 2021-2026 ($ millions)
Figure 72. Middle East & Africa Implantable Infusion Port Sales Market Share by Country (2021-2026)
Figure 73. Middle East & Africa Implantable Infusion Port Sales Market Share by Type (2021-2026)
Figure 74. Middle East & Africa Implantable Infusion Port Sales Market Share by Application (2021-2026)
Figure 75. Egypt Implantable Infusion Port Revenue Growth 2021-2026 ($ millions)
Figure 76. South Africa Implantable Infusion Port Revenue Growth 2021-2026 ($ millions)
Figure 77. Israel Implantable Infusion Port Revenue Growth 2021-2026 ($ millions)
Figure 78. Turkey Implantable Infusion Port Revenue Growth 2021-2026 ($ millions)
Figure 79. GCC Countries Implantable Infusion Port Revenue Growth 2021-2026 ($ millions)
Figure 80. Manufacturing Cost Structure Analysis of Implantable Infusion Port in 2026
Figure 81. Manufacturing Process Analysis of Implantable Infusion Port
Figure 82. Industry Chain Structure of Implantable Infusion Port
Figure 83. Channels of Distribution
Figure 84. Global Implantable Infusion Port Sales Market Forecast by Region (2027-2032)
Figure 85. Global Implantable Infusion Port Revenue Market Share Forecast by Region (2027-2032)
Figure 86. Global Implantable Infusion Port Sales Market Share Forecast by Type (2027-2032)
Figure 87. Global Implantable Infusion Port Revenue Market Share Forecast by Type (2027-2032)
Figure 88. Global Implantable Infusion Port Sales Market Share Forecast by Application (2027-2032)
Figure 89. Global Implantable Infusion Port Revenue Market Share Forecast by Application (2027-2032)


More Publications